Skip to content
Faculty
Agenda
Sponsors
About
Accommodations
Menu
Faculty
Agenda
Sponsors
About
Accommodations
Register Now
Agenda
Welcome Day
Thursday, 2/20/25
6:00 PM - 9:00 PM
Poster Session & Welcome Reception
Day One
Friday, 2/21/25
Breakfast Symposium (Non-CE)
The Evolving Standard of Care in Treating Newly Diagnosed Hematologic Malignancies: PART 1
1L CLL
Indolent Lymphomas
Aggressive Lymphomas
Hodgkin’s
Community Application
Q&A
Networking Break
The Evolving Standard of Care in Treating Newly Diagnosed Hematologic Malignancies: PART 2
1L MPNs+MDS
AML +ALL
NDMM
Debate: Is transplant still the best option for all eligible patients?
Community Application MM
Q&A
Lunch Symposium (Non-CE)
Treating Relapse after Initial Therapy: PART 1
MM Early Relapse
Should CART be used for 2nd line therapy?
MPNs
MDS
Community Application
Q&A
Networking Break
Treating Relapse after Initial Therapy: PART 2
Optimal Sequencing in CLL
Indolent Lymphomas
Hodgkins
Aggressive Lymphomas
Community Application
Q&A
Keynote Speaker (Non-CE)
Day Two
Saturday, 2/22/25
Breakfast Symposium (Non-CE)
Translating T-Cell redirecting Therapies into the Community
Managing CRS in the Community
Managing neurotoxicity in the community
Preventing and Managing Infections
Integrating Bispecifics into Practice
Q&A
Networking Break
Treating Later Relapse: 3L and Beyond
RRMM 3L+
Debate: Later Relapse in MM: CAR-T vs. Bispecifics
Indolent Lymphomas (including CLL)
Aggressive Lymphomas
Community Application
Q&A
Lunch Symposium (Non-CE)
Hot Topics in Hematology
Health Policy
MRD in Hematologic Malignancies
Defining high risk disease in hematologic malignancies
Dealing with Drug Shortages in Oncology
DEI in Heme Malignancies
Q&A
Networking Break
The Evolving Treatment Landscape Across Hematologic Malignancies: What's on the horizon?
Multiple Myeloma
CLL
Indolent Lymphomas
Aggressive Lymphomas
MPNs+ MDS
AML + ALL
Farewell Reception
*Agenda is subject to change.
Experience Nashville, TN
Come for the education.
Stay for the fun.